PRI Conference 2024: Suzi van Es to share insights from upcoming Index with investor attendees
Date
08 October 2024
Location
Toronto, Canada
8-10 October 2024Â
Toronto, CanadaÂ
In-person
![](/img/asset/bWVkaWFsaWJyYXJ5L3ByaS1jb25mZXJlbmNlLTIwMjRfbWFpbi1pbWFnZS12Mi0xNzE1ODU5NjQzLnBuZw==/pri-conference-2024_main-image-v2-1715859643.png?fit=crop&h=1&w=1600&s=a00f599e02bf7145add5cd18f92fb5d8)
At the conference, Suzi plans to speak on the ways companies can apply the Foundation’s research, including findings from the Access to Medicine Index, to improve their own ESG goals. Specifically, she will delve into solutions for the more challenging and complex access-to-medicine issues that many companies aim to incorporate into their investment decisions.Â
In November, after the PRI Conference has taken place, the Foundation will release the 2024 Access to Medicine Index, which will analyse and score some of the world’s leading pharmaceutical companies’ progress on access-to medicine priorities. Companies working toward responsible investing will find the upcoming Index particularly useful for its insights on improving access to healthcare products in low- and middle-income countries, which is in line with the UN’s 2030 Good Health & Well Being goal.Â
About PRIÂ
The PRI is an independent organisation supported by the UN. It educates on the impact of investment decisions on ESG issues and supports its signatories in making investments in line with environmental, social and governance (ESG) principles. The PRI has a long- standing partnership with the Foundation.
![](/img/asset/bWVkaWFsaWJyYXJ5L2RpdnlhLXZlcm1hLmpwZw==/divya-verma.jpg?fit=crop&h=240&w=240&s=ab562e4e3c2aec426e81ac2808804b45)